Table 2 Clinical and pathological characteristics of the study population
From: Serum microRNA signatures and metabolomics have high diagnostic value in gastric cancer
Variable | Patients (n = 80) | Control subjects (n = 82) | P value |
|---|---|---|---|
Age (year) | 65.1 ± 10.5 | 34.8 ± 7.3 | < 0.001 |
Gender | Â | Â | 0.090 |
 Male | 57 | 48 |  |
 Female | 23 | 34 |  |
Tumor size (cm) | 4.27 ± 2.62 |  |  |
  > 5 | 49 |  |  |
  ≥ 5 | 31 |  |  |
TNM stage | |||
 I | 20 |  |  |
 II | 18 |  |  |
 III | 31 |  |  |
 IV | 11 |  |  |
Histological grade | |||
 I | 4 |  |  |
 II | 14 |  |  |
 II~III | 25 |  |  |
 IV | 37 |  |  |
Lauren classification | |||
 Diffuse | 25 |  |  |
 Intestinal | 31 |  |  |
 Mixed | 24 |  |  |
Tumor localization | |||
 Cardia | 19 |  |  |
 Corpus | 8 |  |  |
 Antrum | 43 |  |  |
 Whole | 10 |  |  |